Considering the presented information, this study aimed to evaluate the dynamics of microRNA expression in samples from patients with CML, correlating the results with the stage of the disease and BCR::ABL1 transcript quantification to help in the disease follow-up and prognosis. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.